logo

Biotechnology & Drugs News

Share

Novartis Announces Results From Head-to-head CLARITY Study

Sandoz Says FDA Accepts BLA For Proposed Biosimilar Adalimumab To Humira

Novartis Names Elizabeth Barrett As Oncology Head